BIOCHEMICAL
Vol. 71, No. 4, 1976
A SIMPLE
AND
SPECIFIC
Peter Department
of
June
The
g x
fifth
instar
binding
Wood,
binding
procedures. agree
The
second
suitable
assay4
has
a protein cost of
is
desirable.
cyclic
GMP5
have
not
assays4
*Cyclic Cyclic
binding
achieved
GMP
Surrey.
provides
the
to its
is is
measurement
assay
for
is protein
the
directly
radioimmunoassay.
role
cyclic
of
AMP*l
cyclic
GMPk
2 has
led
to
as
an
a search
measurement.
well
established3 The
on
the
cyclic
Published 6 7 8 require
of
be measured
by
a drawback. impact
a
published
may
in
whole
Specificity
obtained
for
a major
for
levels
messenger
antisera had
Gui Idford,
homogenised
previously
interest
Radioimmunoassay of
3’5’
CYCLIC
Marks
Surrey,
hoppers
used
in
results
methods
purchase
FOR
Vincent
purification.
Urine with
from
be
reported
increasing
alternative for
may further
that
well
and
gregaria
which
than
ASSAY
of
supernatant
Schistocerca
greater
Hartman University
15 min
GMP without
and
Gordon
BINDING
22,1976
protein
cyclic
PROTEIN
Biochemistry,
Received 10,000
LOCUST
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
receptor
of
similar
of
comparable
production receptor cyclic
for
the to
or
AMP
simplicity
procedures
purification
the
bovine-adrenal
measurement GMP of
a specificity
but
that
and the
binding
and
measurement protein
shown
low
by
and
cyclic
AMP
q.
GMP is
used as the abbreviation
AMP as the abbreviation
Copyright 0 1976 by Academic Press, Inc. All rights of reproduction in any form reserved.
for
for
guanosine-3'S'-cyclic
adenosine-3'S'-cyclic
1139
phosphate, phosphate.
Vol.71,No.4,
1976
We have using,
as
whole
desert
tested
in
with
that
which
investigate for
crickets
cyclic
than
excess
and,
of
locusts
of
GMP over I1 as
instar
1969 that
in
confirmed8
GMP from
fifth
nanomoles
cyclic
been later,
the
range
two
cyclic
fraction
at
wide
COMMUNICATIONS
for
reportedlO the
more
recently
specificity
gregaria)
group
contained
have
high
RESEARCH
a supernatant
from
three-fold
BIOPHYSICAL
protein,
different
it to
binding
Sutherland’s
markedly
findings,
of
assay
(Schistocerca
of
a two-
an
of
locusts
Members was
AND
developed
a source
tissue
BIOCHEMICAL
stage.
“Cricket”
mammalian
tissues
cyclic
GMP
cyclic
AMP.
led
a source
us
first
of
binding
per
gram, These
to protein
GMP.
EXPERIMENTAL
Preparation
of
Fifth rapidly
frozen
(250
mM-sucrose; two
blender
ground
extracted 50
15 minutes
decanted
through
stored
at
frozen
preparation
three
months.
Assay
procedure
The
at
10,000
nylon
cloth
-2O’C.
Aliquots maintaining
(at
incubation
at
nylon
liquid
25
2.
10,000
and
(125
5.0
were
9
thawed its
on
cooling for
u pore
resulting ml
The
a
per
an
immediately
and
the
for
was
again
frozen
for
super-
respun
a
and
before
properties
gram,
ice-bath.
supernatant were
cold
‘Polytron’ in
size)
were
medium
15 minutes,
aliquots
binding
g,
15 mM-MgC12)
speed with
The
1.5-2
nitrogen.
mM-KCI;
maximum
cloth
weighing
homogenisation
Limited)
centrifuged
through
7.4; at
Supply
in
ice-cold
pH
periods
was
decanted
further
mM-Tris,
Media
each
a powder
6.0 ml
thirty-second
homogenate
gregaria,
to
with
(Northern
natant
protein
Schistocerca
and
was
using
binding
instar
powder
The
the
use, at
the
least
4’C)
mixture
comprised
1140
100
ul
assay
buffer
(50
mM-HEPES,
Vol.
71,
No. 4,1976
pH
7.4;
BIOCHEMICAL
8 mM-theophylline;
albumin
(Armour))
binding
protein
the
range
One in
mmol),
at
cyclic
of
dissolved
GMP)
[8-3H]
assay and
cyclic
3.8
ice-cold
buffer, the
and
made
up
pmol 100
in
GMP
was
bovine
cyclic
ul
the
of assay
after
100
or
standard
ul
Centre;
for
of (in
buffer.
a thirty
continued
serum
AMP; test
(Radiochemical
added
incubation
COMMUNICATIONS
5 g/l
200
cyclic
GMP was
M-ammonium
‘Whirlimixer’,
thirty
minutes
at
ml
I ,800
distilled
was
transferred
toluene
at
supernatant
1.0
-
water to
a
19
minute
a further
a counting
RESULTS
AND
DISCUSSION
two
to
three
antisera cyclic the
standards
times
to
range
setting-up alter
(MSE
of these
4L’
and
mixed.
the An
Ci/
pre-
two
I2
in GMP
and
a
150-300%
in
standards
in
recovery
sensitivity
taken
up
from
each
Company), the
in tube
four tritium
AMP was in
with
Addition of
1141
by
ml
of
content
not
urine
of
the in
the
assay.
in
were using
The
to
of
assay The
buffer. urine
AMP
amount
locust
assay
pre-treated cyclic
which
a known
with
standards
of
included
radioimmunoassay
addition values
phosphodiesterase
values. the
cyclic
obtained
comparison
for
35%.
The
gave
in
centrifuge).
ml)
and
of
mixed
centrifuged
(0.5 and
ml
were
precipitate
concentrations
laboratory.
tubes
1.0
refrigerated
added
which
those
of
then
Searle
of
than
this
addition
aliquot
(G-5.
cyclic
samples
increased
‘Mistral
aspirated;
urine
recovery
minutes,
was
higher in
ten
efficiency
gave
raised GMP
for
experiments,
buffer,
the
The
scintillant
with
assay
2
by
solution.
‘Minivial’
measured
the
4’C
‘Synperonic-NXP’
Preliminary
separated
sulphate
kept
The
in
is
mg protein);
of
4’C
RESEARCH
hours. Bound
a
pmol
picomole
incubation half
which
(3.5-4.0
50 ul
BIOPHYSICAL
6 mM-Z-mercaptoethanol;
in
O-50
AND
the effect
did cyclic was
not GMP
Vol.
BIOCHEMICAL
71, No. 4, 1976
AND
BIOPHYSICAL
TABLE
Cyclic
GMP
Nine by
levels
random the
in
urine
locust
different
rabbit
radioimmunoassay
LOCUST
binding
based
ASSAY
SAMPLE Cyclic
pm01 /ml
were
I
GMP
Ilmol/!il creatinine
diluted
1 in
method
anti-cyclic is
COMMUNICATIONS
urine
samples
protein
RESEARCH
and
by
GMP antisera on
the
method
I
20
analysed
in
radioinvnunoassay
of of
and
high
with
et
two The
specificity.
Steiner
duplicate
al
(1972).
RADIOIMMUNOASSAY
ANTI SERUM
pm0 1 /ml
1
ANT I SERUM Cyclic
lJmo1/g creatinine
2
GMP
pmol /ml
urn01 /cl creatinine
240
1.18
200
0.99
240
1.18
400
1.22
420
1.28
420
1.28
560
0.92
600
0.98
540
0.89
320
1.14
300
1.07
340
1.21
90
0.50
90
0.50
100
0.56
180
0.64
200
0.71
160
0.57
680
1.19
700
1.23
640
1.12
860
1.26
860
1.26
1000
1.47
400
0.80
360
0.72
380
0.76
1142
BIOCHEMICAL
Vol. 71, No. 4,1976
detectable and
with
was
maximal
affects AMP
per
the (Table
binding
tube
to
of both
in
the
The pmol
excess
ox-heart
content
to
cyclic
in
GMP
the
less
than
than
one-thousandth.
than
one
fi.ftieth
than
that
of
interpreted constants
= 2.4-5.2
x
The in
plasma
replacing resulted
in
use
agreed
well,in
radioimmunoassay
ten
urine
specimens
independent
of
urine
assay
was
pH 7.4
calculated13
to
be
of reduced
urine
samples
the
cyclic
the
assay
with
GMP
fifteen
nucleotides results
avidity
of
cyclic
of
the
as
an
obtained
Cyclic
IMP GMP
nucleotides
of
methods
data
KD,
three
cross-reacted
with
cyclic
AMP
of
= 1.5-2.5
x
with
to
the
considerably
for
revealed
populations
order
with
therefore,
is,
binding
two
and
are
cross-reacted
Specificity
binding
terms
being
cyclic
protein
the
in
cyclic
GMP.
smooth
curves
binding
sites
10mgM
which with
and
10-8M.
of
cyclic
EDTA AMP
theophylline in
to
cyclic
limit.
AMP.
of
pm01
by
added
tube,
AMP
which
GMP were
locust
at
existing
plots
GMP
preparations.
cyclic
200
results
Preincubation
similar
the
cyclic
determined
cyclic
tube.
Other
less
dissociation KD2
the
of 1,
of
per
l:32.
per
protein
Scatchard be
cyclic
AMP
Thus,
gave those
of
detection
Figure
binding
higher
of
of
reactivities
illustrated
or
with
cyclic
addition
tests
phosphodiesterase
Cross
extent
and
to
limit
below
different
the
and
RESEARCH COMMUNICATIONS
5 pmol
GMP
Measurements
1:2
as pmol/tube.
recovery
range
little
100-200
investigated,
detection
0.2-0.3
as
standards
98%.
dilution
of
cyclic
Moreover,
averaged
of
a level
samples
1).
could
addition
at
the
urine
now
the
AND BIOPHYSICAL
a 20-30s
l4
studies by increase
anticoagulant
this
led
us
and to
compound in
zero
investigate in
standard
1143
phsphodiesterase
the
the assay binding
inhibitor effect
This
buffer. but
of
also
markedly
less same
Vol.
BIOCHEMICAL
71, No. 4, 1976
AND
BIOPHYSICAL
NUCLEOTIDE
FIGURE
COMMUNICATIONS
(Ptxd~tUk)
1
Specificity
The
RESEARCH
of
cross
the
reactivities
incubation
of
procedure
A:-
3’5’
D:-
dibutyryl
3’5’
G :-
dibutyryl
3’5’
dTMP,
Method
5’
cyclic
GMP-PNP,
and
(M
and
(W)
not
plotted
increased of
and
specificity
B:-
the
cyclic
cyclic
GMP;
E:-
3’5’
cyclic
AMP;
H:-
Mean
5’
monobutyryl
the
GTP,
2’3’
3’5’
cyclic
means
determined
using
the
test.
3’5’
ATP,
show
in
were
IMP;
cyclic
C:-
3’5’
cyclic
cyclic
AMP;
F:-
result
(2
AMP,
2’3’
SEM)
CMP; 3’5’ for
cyclic
UMP;
cyclic
3’5’
cyclic-
GMP,
AMP-PNP,
UMP.
(+SEM)
of
results
for
AMP.
In
nucleotides
which
are
individually.
the
use
5’
nucleotides
described
GMP;
AMP,
fifteen
cross-reactivity
isobutylmethyl
of xanthine
results
in
cyclic
(8mM) good
in
agreement
1144
the
assay with
contrast buffer
those
to gave
found
for
this,
the
binding theophylline.
Vol.
71, No.
BIOCHEMICAL
4,1976
Binding
protein
differences
in
Tiss.ue
fifth may
specificity
showed instar
much
of
cyclic
The the
Urine be
of
may
to
prior
nucleotide
We thank of
the
or
isolated
than
fourth
or
phenomenon
endocrinology.
fifth
instar will
Locusta
also
be
migratoria
suitable
as
a
protein.
binding
the
advantages
protein
with
without out
of high
on
procedure
specificity
preliminary
measurements
a simple
for
purification, plasma
cyclic and
and
tissue
it
extracts
fractionation.
Shell
Research
locusts
cross-reactivity this
distinct
stages.
insects
of
COMMUNICATIONS
showed
juvenile
whole
species
combines
carry
and
insect
this
analysed
possible
without
gifts
be
AMP
with
binding
method
preparation
GMP . may
locust
adult (either
on
that
GMP
gregaria
investigation
investigations indicated
of
the
studies
RESEARCH
Schistocerca
cyclic
Further in
BIOPHYSICAL
males
greater
interest
migratorioides source
adult
hoppers.
prove
from between
from
Preliminary
for
extracts
preparations
abdomens)
AND
used
Limited
in
this
(Sittingbourne,
Kent,
UK)
for
study.
REFERENCES
1.
‘News
and
2.
Goldberg, Kuehl,
3.
F.A. New
Steiner,
A.L.,
Brown, (1571)
Nature
N.D.,
307-330,
111:
4.
Views’
Haddox,
Jnr.,
and
York:
Albano,
Biochem.J.,
Nature
M.K.,
Nicol,
Estensen,
Raven
Wehman,
Adv.Cyc.Nuc.Res., B.L.,
(1373)
S.E.,
186-187. Glass,
(1975)
In:
D.B.,
Sanford,
Adv.Cyc.Nuc.Res.,
C.H., 5,
Press. R.E.,
2, J.D.M., -121,
R.
246,
Parker,
51-61,
New Ekins,
C.W.
and
Kipnis,
York:
Raven
R.P.,
Sgherzi,
561-562.
1145
D.M.
(1872)
Press. A.M.
and
Tampion,
W.
Vol. 71, No. 4, 1976
5.
6.
Murad,
BIOCHEMICAL
F.,
USA,
-68
Kuo,
J.F.,
Manyaniello,
AND
V.
and
BIOPHYSICAL
Vaughan,
RESEARCH
M.
(1971)
COMMUNICATIONS
Proc.Nat.Acad.Sci.
736-739.
(4)
Wyatt,
G.R.
and
R.
Fang,
Greengard,
P.
(1871)
J.Biol.Chem.,
246,
7159-7167. 7.
Kobayashi,
and
V.S.
(1875)
Biochem.Biophys.Res.Comm.,
G.R.
(1975)
Anal.Biochem.,
2,
5,
305-312.
67
(2)
493-500.
8.
Fal!on,
A.M.
and
9.
Gi Iman,
A.G.
(1870)
10.
Ishikawa, J.Biol
11.
Fallon,
12.
Wood,
E., .Chem., A.M. P.J.,
Lab.Practice Ekins,
R.P.
14.
Tovey,
K.C.,
6,
Proc.Nat.Acad.Sci.USA,
Ishikawa,
S.,
-244 (3), and
G.R. J.,
(11)
(1874) Oldham,
Davis,
J.W.
and
614-619.
Sutherland,
(1969)
E.W.
6371-6376.
Wyatt,
English, 24
13.
Wyatt,
(1975)
Biochim.Biophys.Acta,
Chakraborty,
J.
and
-411,
Hinton,
R.
(1875)
(1874)
Clin.Chim.Acta,
739-740. Br.Med.Bull., K.G.
and
-30 Whelan,
221-234.
1146
(l), J.A.M.
3-11.
173-185.